Mutagenesis after cancer therapy.

A subset of Hodgkin's disease (HD) and breast cancer patients have been reported to have elevated hprt mutant frequencies in peripheral blood lymphocytes after cessation of therapy. A subset of these patients are also known to develop second therapy-related malignancies. Therefore, it is clearl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelsey, K T, Caggana, M, Mauch, P M, Coleman, C N, Clark, J R, Liber, H L
Formato: Texto
Lenguaje:English
Publicado: 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1521128/
https://www.ncbi.nlm.nih.gov/pubmed/8143613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1521128/
https://www.ncbi.nlm.nih.gov/pubmed/8143613

Ejemplares similares